News
GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, ...
vs Non-ALIS Antibiotic Treatment Longitudinal Health Status Improvements Following Culture Conversion in Patients with Mycobacterium Avium Complex Lung Disease Thematic Poster Session B58 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback